Cerus (CERS) News
NASDAQ: CERSHealth CareMedical/Dental InstrumentsUSD
1.85-0.05 (-2.63%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
CERS news summary
We found 4 recent headlines mentioning Cerus (CERS): 0 in the past week and 3 in the past 30 days, most often from Nasdaq, Business Wire. For price context, CERS is down 2.63% at $1.85. The most recent story, "Cerus: 3 Key Takeaways for Long-Term Investors", was published by Nasdaq on Nov 3, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest Cerus headlines
- Cerus: 3 Key Takeaways for Long-Term InvestorsKey PointsPhase III REDeS study met primary efficacy and safety endpoints.Nasdaq
- Cerus (CERS) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The MoNasdaq
- Cerus Corporation Announces Third Quarter 2026 Financial ResultsCONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today financial results for the third quarter ended September 30, 2026, and provided a business update. "Our solid…Business Wire
- Cerus Corporation to Release Third Quarter 2026 Financial Results on November 2, 2026CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (Nasdaq: CERS) announced today that its third quarter 2026 financial results will be released on Monday, November 2, 2026, after the close of the…Business Wire